AGO2 and neoplasm: In addition, blocking Ago2/CAV1 interaction in HCC1806Ago2-KO/AID-Ago2Wt/Ago2∆ cells decreased primary tumor cell dissemination to lymph nodes by 86% (Fig. 5Fiii) and to the lungs by 84% (Fig. 5Fiv).